LOS ANGELES Extreme complications from Type 1 diabetes and renal failure put 55-year-old Danny Parr in the hospital. But medical exams revealed he also has significant coronary artery disease, so he's ...

The Food and Drug Administration is adding its strongest warning to the label for Plavix, cautioning that some patients do not respond to the blockbuster blood thinner. Subscribe to read this story ad ...

The Food and Drug Administration last year warned patients who are taking the anti-clotting drug Plavix against taking the acid-reducing medications Prilosec or Nexium with it because either of the ...

US District Judge Sidney Stein in New York told both sides in the patent trial over the blockbuster blood thinner Plavix to submit their written arguments to him, Bloomberg News reported.By doing so ...

HONOLULU (HawaiiNewsNow) - A lawsuit filed today by the State Attorney General against the makers of Plavix alleges that they marketed a drug in Hawaii that they knew would not work for up to half of ...

Federal health officials are investigating whether the blood thinner Plavix — the world’s second-best-selling drug and used by millions to reduce the risk of heart attack and stroke — may be less ...

A generic form of the Bristol-Myers Squibb anticoagulant Plavix saw launch by Canadian generic drug maker Apotex, delivering a big blow to BMS. The launch came today, shortly after BMS noted in a ...

CHICAGO (CN) - Ten people died from the blockbuster blood-thinner Plavix, which is no better than aspirin against stroke but costs 100 times more, dozens of family members claim in two complaints.

Drug could help patients undergoing angioplasty Could be an alternative to standard anti-clotting drug Study found cangrelor was slightly better at preventing death An experimental new drug may prove ...

This article was originally on a blog post platform and may be missing photos, graphics or links. See About archive blog posts. Advertising brand-name prescription medications directly to patients is ...

Yet another milestone on pharma's journey away from the megablockbuster era: Plavix, the gold-standard clotbuster, goes off patent today. And unlike Pfizer ($PFE ...